SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is experiencing significant attention following its unexpected merger with nuclear fusion firm TAE Technologies, sparking community debate over its strategic pivot and future viability. While some investors celebrate the foray into the energy sector as a visionary move, others express strong skepticism, labeling it a dilution risk. The symbol also continues to draw extensive political commentary, with recent file disclosures fueling further polarized discussions among market participants.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab USA Inc. is surging after securing its largest contract to date, an $816 million prime award from the Space Development Agency to build missile-defense satellites. This significant win is being hailed by the community as strong validation of Rocket Lab's role in the growing defense-space sector, with many anticipating continued long-term growth and further strategic opportunities.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending after announcing a 50/50 joint venture with Romania's state-owned FPCU to create the Western world's first fully integrated rare earth mine-to-processing supply chain in Europe. This strategic partnership, securing 50% of Tanbreez's concentrate production without CRML issuing debt or equity, is seen by many as a significant de-risking event for securing critical mineral supply chains. While some express concern about a delayed Bank Feasibility Study, community discussions are dominated by the potential for substantial EU funding and the geopolitical importance of this move to reduce reliance on China.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is trending as it rebrands to Zero Stack, emphasizing a substantial 0G crypto treasury and AI infrastructure, which the community perceives as a massive undervaluation against its low market capitalization. This strategic pivot, combined with strong speculation of a short squeeze due to its low float, is driving intense discussion and drawing comparisons to past market runners, benefiting from broader optimism in both AI-blockchain innovation and potential cannabis sector reforms.

Cytokinetics, Inc. is a biopharmaceutical company, which is focused on discovering, developing, and commercializing muscle activators and muscle inhibitors as potential treatments for people with debilitating diseases in which muscle performance is compromised and/or declining. The firm is developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Its clinical-stage drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator, CK-136, a novel cardiac troponin activator, reldesemtiv, a novel fast skeletal muscle troponin activator, aficamten, a novel cardiac myosin inhibitor, and CK-3772271, a novel cardiac myosin inhibitor. The company was founded by Ronald D. Vale, Lawrence S. B. Goldstein, James H. Sabry, and James A. Spudich in 1997 and is headquartered in South San Francisco, CA.

Cytokinetics Inc

Cytokinetics is actively trending following the FDA approval of MYQORZO (aficamten) for obstructive hypertrophic cardiomyopathy, a groundbreaking treatment that has ignited widespread discussion. The community is keenly focused on the drug's differentiated and less onerous REMS program compared to rivals, which many believe positions it as a best-in-class therapy. Despite this significant milestone, sentiment is mixed regarding the stock's immediate price action, with many anticipating substantial future upside and renewed buyout speculation.

Newegg Commerce, Inc. is an e-commerce company. It offers direct sales and an online marketplace platform for IT computer components, consumer electronics, entertainment, smart home and gaming products. The firm also provides third-party logistics services globally. The company was founded on July 22, 2003 and is headquartered in City of Industry, CA.

Newegg Commerce Inc

Newegg Commerce is experiencing significant traction following substantial insider share accumulation, which has reportedly tightened the public float. The community is actively discussing the potential for a considerable short and gamma squeeze, driven by allegations of market manipulation and numerous in-the-money call options. Many anticipate a notable upward price movement as these dynamics, coupled with strategic partnerships, continue to unfold.

BigBear.ai Holdings, Inc. engages in data-driven decision dominance and advanced analytics that provide its customers with a competitive advantage in a world driven by data that is growing in terms of volume, variety, and velocity. The firm operationalizes artificial intelligence and machine learning at scale through its end-to-end data analytics platform. It deploys its observe, orient and dominate products to customers throughout the defense, intelligence, and commercial markets. The company was founded in 2020 and is headquartered in McLean, VA.

BigBear.ai Holdings Inc

BigBear.ai is currently trending due to a new strategic partnership with C Speed aimed at delivering AI-enabled border security solutions, fueling investor optimism about its role in defense and national security. The community is also highly engaged and divided over an upcoming proxy vote to increase authorized shares, with many anticipating significant government contracts that could drive substantial growth for the AI firm.

TTM Technologies, Inc. engages in the manufacture and sale of printed circuit boards and backplane assemblies. It operates through the Printed Circuit Board and RF&S Components segments. The Printed Circuit Board segment consists of fifteen domestic PCB and sub-system plants, five PCB fabrication plants in China, and one in Canada. The RF&S Components segment consists of one domestic RF component plant and one RF component plant in China. The company offers products such as backplanes, system integration, chassis assemblies, integrated circuit substrates and chips, and engineering services. The company was founded on March 20, 1978 and is headquartered in Santa Ana, CA.

TTM Technologies Inc

TTM Technologies is currently trending amid recent analyst upgrades and robust bullish sentiment, highlighting its critical role in both the expanding AI ecosystem and the resilient defense sector. The community actively discusses actionable trade opportunities, frequently calling TTMI an "absolute monster" stock given its high-density interconnect (HDI) PCBs are vital for advanced computing and aerospace applications.

McKesson Corp. engages in providing healthcare services. It operates through the following segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs. The RxTS segment offers prescription price transparency, benefit insight, dispensing support services, third-party logistics, and wholesale distribution. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The International segment refers to the distribution and services to wholesale, institutional, and retail customers in Europe and Canada. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.

Mckesson Corporation

McKesson ($MCK) is currently trending as a potential rebound play, with numerous community trade alerts highlighting its oversold technical conditions and low RSI. This sentiment for a bullish reversal is reinforced by a wave of recent analyst upgrades and raised price targets from various financial institutions, underscoring confidence in the healthcare distribution giant's stability and strategic moves.

AppLovin Corp. engages in the development and operation of a mobile marketing platform. It offers AppDiscovery, MAX, Adjust, and SparkLabs. Its software-based platform caters to mobile application developers to improve the marketing and monetization of applications. The company was founded by Andrew Karam, John Krystynak, and Adam Foroughi in 2011 and is headquartered in Palo Alto, CA.

Applovin Corp - Ordinary Shares - Class A

Applovin Corp

Applovin is trending due to recent analyst upgrades and its strong financial performance, highlighting impressive margins and AI-driven growth in its ad platform. This fuels a heated debate within the community, with many anticipating continued rallies and a short squeeze, while others express strong concerns over extreme valuation, ongoing regulatory scrutiny, and allegations of questionable business practices. The ad-tech firm's expansion into e-commerce and its position in a volatile market are central to the polarized conversation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Precigen (NASDAQ:PGEN) Trading 5.3% Higher - Here's What Happened

Precigen (NASDAQ:PGEN) Shares Up 5.3% - Should You Buy...

Diametric Capital LP Buys New Holdings in Precigen, Inc. $PGEN

Diametric Capital LP purchased a new position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) in the 2nd quarter, according to the company in its most recent filing with the Securities and...

Patient Capital Management LLC Sells 1,103,560 Shares of Precigen, Inc. $PGEN

Patient Capital Management LLC trimmed its position in shares of Precigen, Inc. (NASDAQ:PGEN - Free Report) by 6.4% during the second quarter, according to the company in its most recent Form 13F...

Precigen, Inc. (NASDAQ:PGEN) Receives Average Rating of "Moderate Buy" from Brokerages

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six research firms that are currently covering the company, Marketbeat Ratings reports. One...

Precigen (NASDAQ:PGEN) Trading Down 4.9% - Here's Why

Precigen (NASDAQ:PGEN) Stock Price Down 4.9% - Should You Sell...

Insider Selling: Precigen (NASDAQ:PGEN) Director Sells 942,832 Shares of Stock

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 942,832 shares of the business's stock in a transaction on Thursday, November 20th. The shares were sold at an average price...

Precigen (NASDAQ:PGEN) Director Sells 1,086,153 Shares

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 1,086,153 shares of the business's stock in a transaction that occurred on Wednesday, November 19th. The stock was sold at an...

Precigen (NASDAQ:PGEN) Director Sells $3,589,889.64 in Stock

Precigen, Inc. (NASDAQ:PGEN - Get Free Report) Director Randal Kirk sold 937,308 shares of the company's stock in a transaction on Friday, November 21st. The shares were sold at an average price of...

Precigen (NASDAQ:PGEN) Stock Price Down 9% - Time to Sell?

Precigen (NASDAQ:PGEN) Shares Down 9% - Time to Sell...

Precigen (NASDAQ:PGEN) Announces Quarterly Earnings Results, Misses Expectations By $0.03 EPS

Precigen (NASDAQ:PGEN - Get Free Report) released its quarterly earnings data on Thursday. The biotechnology company reported ($1.06) earnings per share for the quarter, missing analysts' consensus...

Precigen, Inc. is a biotechnology company, which engages in the research and development of synthetic biology technologies. It operates through the following segments: Biopharmaceuticals, Exemplar, and Trans Ova. The Biopharmaceuticals segment is involved in advancing the next generation of gene and cell therapies using precision technology to target urgent and intractable diseases in immuno-oncology, autoimmune disorders, and infectious diseases. It also engages in pioneering a proprietary class of microbe-based biopharmaceuticals that enable expression and local delivery of disease-modifying therapeutics. The Exemplar segment is focused on developing research models and services for healthcare research applications. The Trans Ova segment provides bovine reproductive technologies. The company was founded by Thomas David Reed in 1998 and is headquartered in Germantown, MD.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	-$0.08	--	--	N/A
Q3 '25	-$0.09	-$1.06	-1029.46%	MISSED
Q2 '25	-$0.09	-$0.09	0.02%	BEAT
Q1 '25	-$0.18	-$0.18	--	EXPECTED
Q4 '24	-$0.05	-$0.07	-40.35%	MISSED

PGEN
Precigen Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest PGEN News

PGENPrecigen Inc